Stentorian Ventures is a venture capital firm that integrates impact investing with the deployment of technical expertise to drive innovations in cancer research from bench to bedside.
The group's mission is to lead innovation and provide solutions to many of today's critical safety, health, and environmental problems. Stentorian Ventures is launching a $2M seed-stage venture fund in San Diego, CA, to Combat Cancer Through Innovation and Technology.
DDG is excited to work with Stentorian Ventures and continue to evolve the group's new identity that will express its purpose more accurately.
